Clinical Trial Update: IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intravenous immunoglobulin (IVIG) for metastatic prostate, colon, and malignant melanoma cancers; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Malignant Melanoma
• Prostate Cancer

Drugs mentioned

• IVIG (intravenous immunoglobulin)

Snippet

Sponsor: GammaCan | Conditions: Cancer of Colon, Malignant Melanoma | Phase 2 | Status: UNKNOWN